Related Experiment Videos
'Wonder drugs' for psoriasis a never ending story
American Journal of Clinical Dermatology
|November 14, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Depression, a major comorbidity of psoriatic disease, is caused by metabolic inflammation.
Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Long-term efficacy and safety of brodalumab in moderate-to-severe plaque psoriasis: a post hoc pooled analysis of AMAGINE-2 and -3.
Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Effect of baseline disease severity on achievement of treatment target with apremilast: results from a pooled analysis.
Journal of the European Academy of Dermatology and Venereology : JEADV·2021
[Systemic treatment of moderate/severe hidradenitis suppurativa].
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2021
ActiPso: definition of activity types for psoriatic disease: A novel marker for an advanced disease classification.
Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Association of sex and systemic therapy treatment outcomes in psoriasis: a two-country, multicentre, prospective, noninterventional registry study.
The British journal of dermatology·2021
Sex Hormones in Psoriatic Disease: A Systematic Review.
American journal of clinical dermatology·2026
Cutaneous Aging in Skin of Color: A Narrative Review.
American journal of clinical dermatology·2026
Efficacy and Safety of SSGJ-608 in Moderate-to-Severe Plaque Psoriasis: A Pivotal Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase III Clinical Trial.
American journal of clinical dermatology·2026
Impact of Biologic Therapies on the Risk of Progression from Psoriasis to Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Cohort Studies.
American journal of clinical dermatology·2026
Deucravacitinib 5-Year Safety and Efficacy Results in Plaque Psoriasis: A Phase 3 Open-Label Extension of Randomized Clinical Trials.
American journal of clinical dermatology·2026
Systemic Comorbidities of Keloid and Hypertrophic Scars: A Phenome-Wide Association Study in a Multiethnic U.S. Pediatric Cohort.
American journal of clinical dermatology·2026
Treatment of Isolated Nail Psoriasis with JAK Inhibitor Tofacitinib: A Case Report.
Clinical, cosmetic and investigational dermatology·2026
Correction: Almeida et al. Diterpenes: Nature's Hidden Gems of Immunomodulation. Int. J. Mol. Sci. 2025, 26, 2250.
International journal of molecular sciences·2026
Corrigendum to: The Integration of Systematic Pharmacology and Experimental Validation to Explain the Mechanism of Action of Wuling Capsule in the Treatment of NAFLD.
Combinatorial chemistry & high throughput screening·2026
Poorly labeled CBD and related cannabinoid oils marketed in Europe: a hidden risk for consumers? Insights from a long-term study.
Analytical and bioanalytical chemistry·2026